Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Using PRP treatment after ACL reconstruction to improve recovery

Official title: The Efficiency and Safety of Platelet-rich Plasma Intra-articular Injections After Anterior Cruciate Ligament Reconstruction: MRI and Clinical Outcome Analysis.

Run by Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz · NCT06442319 · Data updated 2026-11-12

This study is testing if using platelet-rich plasma (PRP) after ACL surgery can help people heal better and lower their chances of developing arthritis.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment60 (estimated)
SponsorNicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz
Academic / other
Locations1 site (Torun)
StatusRecruiting
StartedJune 1, 2024
Main results expectedApril 15, 2028
Study endsApril 15, 2030
Registry record updatedJune 4, 2024
Trial IDNCT06442319 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18-45 who have undergone ACL reconstruction and meet specific health criteria.

Probably not a fit

Patients with metabolic diseases, previous knee surgeries, or those who have received intra-articular injections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the efficiency and safety of platelet-rich plasma (PRP) treatment following anterior cruciate ligament (ACL) reconstruction. ACL injuries are common and often lead to long-term complications such as osteoarthritis. The trial aims to assess whether PRP can enhance healing and reduce the risk of arthritis after surgery. Participants will be monitored for their recovery and any adverse effects associated with the treatment.

Why it matters

Potential benefit: If successful, this treatment could significantly improve recovery outcomes and reduce the incidence of arthritis in patients after ACL reconstruction.

How similar studies have gone: Other studies have shown promising results with PRP treatment in similar contexts, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* subject is 18-45 years old
* subject has BMI \< 40 kg/m2
* subject had ACL reconstrution
* small asymptomatic meniscal lesions that won't require repair
* subject must be willing to abstain from other intra-articular treatments of the knee for the duration of the study.
* subject is willing to discontinue all analgesics including nonsteroidal anti-inflammatory drugs (NSAIDs), except tramadol and paracetamol, at least one month before the synovial fluid aspiration and through the completion of the study
* subject is able to understand and comply with the requirements of the study and voluntarily provides consent

Exclusion Criteria:

* subject has a history of metabolic diseases, endocrine disorders, rheumatic and connective tissue diseases, cancer, hormonal contraception, steroid therapy, antibiotic therapy
* subject had an intraarticular injection into the affected joint
* subject had previous operations (beside ACL reconstruction) or fractures of the affected limb
* subject has a history of nicotine, alcohol, or drug addiction
* subject has a meniscal tear that requires suturing or total meniscectomy seen on MRI
* subject has multi-ligament knee injuries or multi-organ injury
* subject has significant varus or valgus deformity greater than 10 degrees in either knee, determined by an X-ray

Where it's running

  • Dawid Szwedowski
    Torun, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.